Author

Zara A. Barger

UNSW SydneyORCID 0009-0002-6421-3876Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

Chelsea MayohiD· 2 shared Emmy D.G. FleureniD· 2 shared Marie WongiD· 2 shared Alice SalibiD· 1 shared Alvin KamiliiD· 1 shared Andrew J. GiffordiD· 1 shared Angela LiniD· 1 shared Antoine de WeckiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Chelsea MayohORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 21, 2026

METTL1 gene dosage and catalytic activity define a targetable vulnerability in pediatric cancers

Pei Yan Liu, Steven He, Olesya O. Panasenko…·Paul G. Ekert

This study identifies METTL1 gene dosage and catalytic activity as therapeutic targets in pediatric cancers, showing that inhibiting METTL1 synergizes with BCL-xL inhibitors.

DOI 10.64898/2026.10.20.760582

humanexperimental assay

𝕏 PostBluesky

Cancer BiologyMolecular Systems BiologyPeer-reviewedOct 1, 2025

Engineered paediatric tumours retain patient tumour genotype and phenotype for precision medicine.

MoonSun Jung, Valentina Poltavets, Joanna N. Skhinas…·Maria Kavallaris

This paper develops patient-derived tumour models using engineered ECM hydrogels to enable precision medicine for paediatric cancers by retaining tumour genotype and phenotype.

10 citations

humanbulk RNA-seq

𝕏 PostBluesky